# Stuart J. Connolly

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stuart-j-connolly/

## Facts

| Field | Value |
| --- | --- |
| Citations | 80,952 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 133 |
| i10-index | 428 |
| Last Known Institution | Population Health Research Institute |
| OpenAlex ID | https://openalex.org/A5079046512 |
| ORCID iD | https://orcid.org/0000-0002-7377-335X |
| Works | 724 |

## Researcher papers

- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Subclinical Atrial Fibrillation and the Risk of Stroke](https://scholariq.org/papers/subclinical-atrial-fibrillation-and-the-risk-of-stroke/)
- [Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure](https://scholariq.org/papers/cardiac-resynchronization-therapy-for-mild-to-moderate-heart-failure/)
- [Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation](https://scholariq.org/papers/effect-of-dronedarone-on-cardiovascular-events-in-atrial-fibrillation/)
- [Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events](https://scholariq.org/papers/temporal-relationship-between-subclinical-atrial-fibrillation-and-embolic-events/)
- [Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT](https://scholariq.org/papers/duration-of-device-detected-subclinical-atrial-fibrillation-and-occurrence-of/)
- [Screening for Atrial Fibrillation](https://scholariq.org/papers/screening-for-atrial-fibrillation/)
- [The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study](https://scholariq.org/papers/the-novel-biomarker-based-abc-age-biomarkers-clinical-history-bleeding-risk/)
- [New-Onset Atrial Fibrillation](https://scholariq.org/papers/new-onset-atrial-fibrillation/)
- [Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial](https://scholariq.org/papers/dabigatran-in-patients-with-myocardial-injury-after-non-cardiac-surgery-manage/)
- [Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study](https://scholariq.org/papers/safety-of-the-oral-factor-xia-inhibitor-asundexian-compared-with-apixaban-in/)
- [Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial](https://scholariq.org/papers/rivaroxaban-or-aspirin-for-patent-foramen-ovale-and-embolic-stroke-of/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)

## Researcher university

- [Population Health Research Institute](https://scholariq.org/institutions/population-health-research-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.